Bioglan Gaining Four Medicis Dermatologic Products With $16 Mil. In Sales
This article was originally published in The Tan Sheet
Executive Summary
The British firm Bioglan Pharma is adding the OTC dermatological products Zostrix, Exorex and Theraplex and the prescription derm product Zonalon to its product portfolio. The expansion of the Bioglan product line is being made under an agreement with Medicis Pharmaceutical announced June 29 that will require the payment of $40 mil. cash and certain licensed technologies.